PL2227488T3 - FVIII Peptydy i ich zastosowanie w indukcji tolerancji u chorych na hemofilię - Google Patents

FVIII Peptydy i ich zastosowanie w indukcji tolerancji u chorych na hemofilię

Info

Publication number
PL2227488T3
PL2227488T3 PL08855772T PL08855772T PL2227488T3 PL 2227488 T3 PL2227488 T3 PL 2227488T3 PL 08855772 T PL08855772 T PL 08855772T PL 08855772 T PL08855772 T PL 08855772T PL 2227488 T3 PL2227488 T3 PL 2227488T3
Authority
PL
Poland
Prior art keywords
fviii peptides
tolerising
haemophiliacs
tolerising haemophiliacs
fviii
Prior art date
Application number
PL08855772T
Other languages
English (en)
Other versions
PL2227488T6 (pl
Inventor
David Wraith
Original Assignee
Apitope Int Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apitope Int Nv filed Critical Apitope Int Nv
Publication of PL2227488T3 publication Critical patent/PL2227488T3/pl
Publication of PL2227488T6 publication Critical patent/PL2227488T6/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL08855772T 2007-12-04 2008-12-03 FVIII Peptydy i ich zastosowanie w indukcji tolerancji u chorych na hemofilię PL2227488T6 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0723712.6A GB0723712D0 (en) 2007-12-04 2007-12-04 Peptides
PCT/GB2008/003996 WO2009071886A1 (en) 2007-12-04 2008-12-03 Fviii peptides and their use in tolerising haemophiliacs
EP08855772.3A EP2227488B3 (en) 2007-12-04 2008-12-03 Fviii peptides and their use in tolerising haemophiliacs

Publications (2)

Publication Number Publication Date
PL2227488T3 true PL2227488T3 (pl) 2014-07-31
PL2227488T6 PL2227488T6 (pl) 2015-04-30

Family

ID=38982965

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08855772T PL2227488T6 (pl) 2007-12-04 2008-12-03 FVIII Peptydy i ich zastosowanie w indukcji tolerancji u chorych na hemofilię

Country Status (25)

Country Link
US (1) US8445448B2 (pl)
EP (1) EP2227488B3 (pl)
JP (2) JP5501245B2 (pl)
KR (1) KR101519840B1 (pl)
CN (2) CN101889024B (pl)
AU (1) AU2008332968B2 (pl)
BR (1) BRPI0820143A2 (pl)
CA (2) CA3005013C (pl)
CY (1) CY1115168T1 (pl)
DK (1) DK2227488T6 (pl)
EA (1) EA019370B1 (pl)
EC (1) ECSP10010327A (pl)
ES (1) ES2458315T7 (pl)
GB (1) GB0723712D0 (pl)
HR (1) HRP20140344T4 (pl)
IL (1) IL205780A (pl)
MX (1) MX2010006084A (pl)
MY (1) MY150995A (pl)
NZ (1) NZ585217A (pl)
PL (1) PL2227488T6 (pl)
PT (1) PT2227488E (pl)
SI (1) SI2227488T1 (pl)
UA (1) UA101003C2 (pl)
WO (1) WO2009071886A1 (pl)
ZA (1) ZA201002997B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001278637B2 (en) 2000-08-21 2006-05-25 Apitope Technology (Bristol) Limited Peptide selection method
GB0801513D0 (en) * 2008-01-28 2008-03-05 Circassia Ltd Peptides from factor VIII
AU2009264282B2 (en) * 2008-06-24 2013-04-18 Octapharma Ag A process of purifying coagulation factor VIII
GB0908515D0 (en) * 2009-05-18 2009-06-24 Apitope Technology Bristol Ltd Peptide
CA2765657A1 (en) * 2009-06-16 2010-12-23 Tokai University Anti-gram-negative bacteria agent
SG189914A1 (en) 2010-10-27 2013-06-28 Baxter Int Fviii peptides for immune tolerance induction and immunodiagnostics
PL2802668T3 (pl) 2012-01-12 2019-03-29 Bioverativ Therapeutics Inc. Sposoby zmniejszania immunogenności wobec czynnika krzepnięcia viii u pacjentów poddawanych leczeniu czynnikiem krzepnięcia viii
ES2626881T3 (es) * 2012-11-12 2017-07-26 Apitope International Nv Péptidos derivados del factor VIII para uso en el tratamiento de la hemofilia A
GB201314052D0 (en) 2013-08-06 2013-09-18 Apitope Int Nv Peptides
EP4212547A1 (en) 2015-12-03 2023-07-19 Juno Therapeutics, Inc. Modified chimeric receptors and related compositions and methods
US12257288B2 (en) 2016-12-02 2025-03-25 Bioverativ Therapeutics Inc. Methods of inducing immune tolerance to clotting factors
US12077607B2 (en) * 2021-09-23 2024-09-03 University Of Utah Research Foundation Functional and therapeutic effects of PAR4 cleavage by cathepsin G

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5930890A (en) 1989-06-20 1991-01-08 Scripps Clinic And Research Foundation The phospholipid binding domain of factor viii
EP0988056B1 (en) * 1997-01-22 2003-07-09 Board Of Regents, The University Of Texas System Tissue factor methods and compositions for coagulation and tumor treatment
AU2001278637B2 (en) 2000-08-21 2006-05-25 Apitope Technology (Bristol) Limited Peptide selection method
WO2002060917A2 (en) 2000-12-01 2002-08-08 Regents Of The University Of Minnesota Method to treat hemophilia
KR20040074587A (ko) * 2001-02-19 2004-08-25 메르크 파텐트 게엠베하 감소된 면역원성을 갖는 인공 단백질
WO2002098454A2 (en) * 2001-05-31 2002-12-12 D. Collen Research Foundation Vzw Onderwijsen Navorsing Campus Gasthuisberg K.U. Leuven Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools
WO2003087161A1 (en) * 2002-04-18 2003-10-23 Merck Patent Gmbh Modified factor viii
EP1729795B1 (en) * 2004-02-09 2016-02-03 Human Genome Sciences, Inc. Albumin fusion proteins
WO2006003183A1 (de) 2004-07-02 2006-01-12 Alois Jungbauer Peptide zur blockierung von fviii-inhibitoren
IL229645A0 (en) * 2013-11-26 2014-03-31 Omrix Biopharmaceuticals Ltd A dry bandage containing thrombin and pectin

Also Published As

Publication number Publication date
UA101003C2 (uk) 2013-02-25
US20100323966A1 (en) 2010-12-23
EA201070681A1 (ru) 2010-10-29
US8445448B2 (en) 2013-05-21
KR20100087346A (ko) 2010-08-04
CA3005013C (en) 2021-11-16
NZ585217A (en) 2012-11-30
DK2227488T3 (da) 2014-04-22
ZA201002997B (en) 2011-07-27
EP2227488B3 (en) 2014-11-19
ECSP10010327A (es) 2010-09-30
ES2458315T7 (es) 2015-02-18
AU2008332968B2 (en) 2014-03-20
MY150995A (en) 2014-03-31
HRP20140344T4 (hr) 2015-07-31
PL2227488T6 (pl) 2015-04-30
JP6063402B2 (ja) 2017-01-18
JP5501245B2 (ja) 2014-05-21
CN103709234A (zh) 2014-04-09
SI2227488T1 (sl) 2014-06-30
IL205780A (en) 2015-06-30
KR101519840B1 (ko) 2015-05-18
EP2227488A1 (en) 2010-09-15
CN101889024A (zh) 2010-11-17
IL205780A0 (en) 2010-11-30
JP2014088440A (ja) 2014-05-15
CA3005013A1 (en) 2009-06-11
HRP20140344T1 (en) 2014-05-09
ES2458315T3 (es) 2014-04-30
EA019370B1 (ru) 2014-03-31
CN101889024B (zh) 2014-04-23
BRPI0820143A2 (pt) 2015-05-12
DK2227488T6 (en) 2015-02-16
CA2707559C (en) 2018-07-03
MX2010006084A (es) 2010-06-23
EP2227488B1 (en) 2014-01-22
CY1115168T1 (el) 2016-12-14
AU2008332968A1 (en) 2009-06-11
WO2009071886A1 (en) 2009-06-11
GB0723712D0 (en) 2008-01-16
CN103709234B (zh) 2017-01-18
JP2011505414A (ja) 2011-02-24
CA2707559A1 (en) 2009-06-11
HK1144292A1 (en) 2011-02-11
PT2227488E (pt) 2014-04-21

Similar Documents

Publication Publication Date Title
IL205780A0 (en) Fviii peptides and their use in tolerising haemophiliacs
GB0702020D0 (en) Peptides and their use
IL218776A0 (en) Modified factor vii polypeptides and uses thereof
EP2262840A4 (en) METALLOPROTEINASE 9 AND METALLOPROTEINASE 2 BINDING PROTEINS
GB0712670D0 (en) Isolated peptides and uses thereof
GB0708376D0 (en) Novel polypeptides and uses thereof
EP1976864A4 (en) NEW PEPTIDE AND ITS USE
GB0702021D0 (en) Peptides and their use
IL185308A0 (en) Replikin peptides and uses thereof
GB0702022D0 (en) Peptides and their use
IL195525A0 (en) Replikin peptides and uses thereof
GB2445598B (en) Portable device and receptacle therefor
SI2465523T1 (sl) FVIII-derivirani peptidi in njihova uporaba pri toleriranju hemofilikov
PL2222692T3 (pl) Syntetyczny peptyd wiążący się z ludzkim CD154 i jego zastosowania
IL211040A (en) Melanoma antigen peptide and uses
ZA200801874B (en) Antigenic peptides and their use
GB0607798D0 (en) Novel polypeptides and use thereof
GB0604187D0 (en) Peptide and uses thereof
GB0520309D0 (en) Improvements in and relating to flooring
IL192800A0 (en) Fgf2-binding peptides and uses thereof
GB0617564D0 (en) Peptides and methods
GB0710813D0 (en) Peptides and uses thereof
IL184026A0 (en) Use of taa peptides and antibodies in the detection of cancer
GB0823492D0 (en) Antigenic peptides and uses thereof
GB0816561D0 (en) Peptides and uses thereof